{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T21:25:35Z","timestamp":1670621135541},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110180","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:33:35Z","timestamp":1597473215000},"page":"110180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients"],"prefix":"10.1016","volume":"144","author":[{"given":"Bragi","family":"Lovetrue","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110180_b0005","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Jiang, M., Gao, L., & Huang, X., Single cell analysis of ACE2 expression reveals the potential targets for 2019-nCoV. (2020). doi:10.20944\/PREPRINTS202002.0221.V1.","DOI":"10.20944\/preprints202002.0221.v1"},{"key":"10.1016\/j.mehy.2020.110180_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db12-0808","article-title":"Activation of the ACE2\/angiotensin-(1\u20137)\/mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors","volume":"62","author":"Jarajapu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2020.110180_b0015","first-page":"1","article-title":"The ACE2\/Ang-(1\u20137)\/Mas axis regulates the develop- ment of pancreatic endocrine cells in mouse embryos","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110180_b0020","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.mehy.2020.110180_b0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbagrm.2013.09.007","article-title":"The transcrip- tion factor HNF1\u03b1 induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs","volume":"1829","author":"Pedersen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2020.110180_b0030","doi-asserted-by":"crossref","article-title":"Tissue-specific expression of angiotensin-converting enzyme 2 (ACE2) from two promoter regions is unaffected by elevated levels of renin and angiotensinogen","author":"Nguyen","year":"2012","journal-title":"FASEB J","DOI":"10.1096\/fasebj.26.1_supplement.1134.9"},{"key":"10.1016\/j.mehy.2020.110180_b0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.110180_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","article-title":"Accessory proteins of SARS-CoV and other coronaviruses","volume":"109","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.110180_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2019.02.014","article-title":"Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway","volume":"42","author":"van Montfort","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2020.110180_b0055","unstructured":"Zhou, Y. et al. PERSPECTIVE Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients."},{"key":"10.1016\/j.mehy.2020.110180_b0060","first-page":"1","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study","volume":"6736","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110180_b0065","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"1\u201313","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110180_b0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0075","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1161\/STROKEAHA.112.667063","article-title":"Impact of ACE2 deficiency and oxidative stress on cerebrovas-cular function with aging","volume":"43","author":"Pe\u00f1a-Silva","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2020.110180_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00012","article-title":"Source of chronic inflammation in aging","volume":"5","author":"Sanada","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.mehy.2020.110180_b0085","doi-asserted-by":"crossref","unstructured":"Mao, L. et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 2020.02.22.20026500 (2020). doi:10.1101\/2020.02.22.20026500.","DOI":"10.1101\/2020.02.22.20026500"},{"key":"10.1016\/j.mehy.2020.110180_b0090","first-page":"1","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"2600","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.110180_b0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science (80-)"},{"key":"10.1016\/j.mehy.2020.110180_b0100","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.mehy.2020.110180_b0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/bloodadvances.2017005561","article-title":"Proliferation through activation: Hemophagocytic lymphohistiocytosis in hematologic malignancy","volume":"1","author":"Vick","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.mehy.2020.110180_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock","year":"2015","journal-title":"Am J Hematol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T01:22:02Z","timestamp":1667784122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720325408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S0306987720325408"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2020.110180","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":["General Medicine"],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Demiurge Technologies AG. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110180"}}
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T21:25:35Z","timestamp":1670621135541},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110180","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:33:35Z","timestamp":1597473215000},"page":"110180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients"],"prefix":"10.1016","volume":"144","author":[{"given":"Bragi","family":"Lovetrue","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110180_b0005","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Jiang, M., Gao, L., & Huang, X., Single cell analysis of ACE2 expression reveals the potential targets for 2019-nCoV. (2020). doi:10.20944\/PREPRINTS202002.0221.V1.","DOI":"10.20944\/preprints202002.0221.v1"},{"key":"10.1016\/j.mehy.2020.110180_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db12-0808","article-title":"Activation of the ACE2\/angiotensin-(1\u20137)\/mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors","volume":"62","author":"Jarajapu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2020.110180_b0015","first-page":"1","article-title":"The ACE2\/Ang-(1\u20137)\/Mas axis regulates the develop- ment of pancreatic endocrine cells in mouse embryos","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110180_b0020","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.mehy.2020.110180_b0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbagrm.2013.09.007","article-title":"The transcrip- tion factor HNF1\u03b1 induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs","volume":"1829","author":"Pedersen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2020.110180_b0030","doi-asserted-by":"crossref","article-title":"Tissue-specific expression of angiotensin-converting enzyme 2 (ACE2) from two promoter regions is unaffected by elevated levels of renin and angiotensinogen","author":"Nguyen","year":"2012","journal-title":"FASEB J","DOI":"10.1096\/fasebj.26.1_supplement.1134.9"},{"key":"10.1016\/j.mehy.2020.110180_b0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.110180_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","article-title":"Accessory proteins of SARS-CoV and other coronaviruses","volume":"109","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.110180_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2019.02.014","article-title":"Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway","volume":"42","author":"van Montfort","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2020.110180_b0055","unstructured":"Zhou, Y. et al. PERSPECTIVE Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients."},{"key":"10.1016\/j.mehy.2020.110180_b0060","first-page":"1","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study","volume":"6736","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110180_b0065","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"1\u201313","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110180_b0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0075","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1161\/STROKEAHA.112.667063","article-title":"Impact of ACE2 deficiency and oxidative stress on cerebrovas-cular function with aging","volume":"43","author":"Pe\u00f1a-Silva","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2020.110180_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00012","article-title":"Source of chronic inflammation in aging","volume":"5","author":"Sanada","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.mehy.2020.110180_b0085","doi-asserted-by":"crossref","unstructured":"Mao, L. et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 2020.02.22.20026500 (2020). doi:10.1101\/2020.02.22.20026500.","DOI":"10.1101\/2020.02.22.20026500"},{"key":"10.1016\/j.mehy.2020.110180_b0090","first-page":"1","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"2600","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.110180_b0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science (80-)"},{"key":"10.1016\/j.mehy.2020.110180_b0100","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.mehy.2020.110180_b0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/bloodadvances.2017005561","article-title":"Proliferation through activation: Hemophagocytic lymphohistiocytosis in hematologic malignancy","volume":"1","author":"Vick","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.mehy.2020.110180_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock","year":"2015","journal-title":"Am J Hematol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T01:22:02Z","timestamp":1667784122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720325408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S0306987720325408"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2020.110180","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":["General Medicine"],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Demiurge Technologies AG. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110180"}}
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T21:25:35Z","timestamp":1670621135541},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110180","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:33:35Z","timestamp":1597473215000},"page":"110180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients"],"prefix":"10.1016","volume":"144","author":[{"given":"Bragi","family":"Lovetrue","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110180_b0005","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Jiang, M., Gao, L., & Huang, X., Single cell analysis of ACE2 expression reveals the potential targets for 2019-nCoV. (2020). doi:10.20944\/PREPRINTS202002.0221.V1.","DOI":"10.20944\/preprints202002.0221.v1"},{"key":"10.1016\/j.mehy.2020.110180_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db12-0808","article-title":"Activation of the ACE2\/angiotensin-(1\u20137)\/mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors","volume":"62","author":"Jarajapu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2020.110180_b0015","first-page":"1","article-title":"The ACE2\/Ang-(1\u20137)\/Mas axis regulates the develop- ment of pancreatic endocrine cells in mouse embryos","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110180_b0020","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.mehy.2020.110180_b0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbagrm.2013.09.007","article-title":"The transcrip- tion factor HNF1\u03b1 induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs","volume":"1829","author":"Pedersen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2020.110180_b0030","doi-asserted-by":"crossref","article-title":"Tissue-specific expression of angiotensin-converting enzyme 2 (ACE2) from two promoter regions is unaffected by elevated levels of renin and angiotensinogen","author":"Nguyen","year":"2012","journal-title":"FASEB J","DOI":"10.1096\/fasebj.26.1_supplement.1134.9"},{"key":"10.1016\/j.mehy.2020.110180_b0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.110180_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","article-title":"Accessory proteins of SARS-CoV and other coronaviruses","volume":"109","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.110180_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2019.02.014","article-title":"Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway","volume":"42","author":"van Montfort","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2020.110180_b0055","unstructured":"Zhou, Y. et al. PERSPECTIVE Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients."},{"key":"10.1016\/j.mehy.2020.110180_b0060","first-page":"1","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study","volume":"6736","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110180_b0065","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"1\u201313","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110180_b0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0075","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1161\/STROKEAHA.112.667063","article-title":"Impact of ACE2 deficiency and oxidative stress on cerebrovas-cular function with aging","volume":"43","author":"Pe\u00f1a-Silva","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2020.110180_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00012","article-title":"Source of chronic inflammation in aging","volume":"5","author":"Sanada","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.mehy.2020.110180_b0085","doi-asserted-by":"crossref","unstructured":"Mao, L. et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 2020.02.22.20026500 (2020). doi:10.1101\/2020.02.22.20026500.","DOI":"10.1101\/2020.02.22.20026500"},{"key":"10.1016\/j.mehy.2020.110180_b0090","first-page":"1","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"2600","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.110180_b0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science (80-)"},{"key":"10.1016\/j.mehy.2020.110180_b0100","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.mehy.2020.110180_b0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/bloodadvances.2017005561","article-title":"Proliferation through activation: Hemophagocytic lymphohistiocytosis in hematologic malignancy","volume":"1","author":"Vick","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.mehy.2020.110180_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock","year":"2015","journal-title":"Am J Hematol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T01:22:02Z","timestamp":1667784122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720325408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S0306987720325408"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2020.110180","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":["General Medicine"],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Demiurge Technologies AG. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110180"}}
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T21:25:35Z","timestamp":1670621135541},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110180","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:33:35Z","timestamp":1597473215000},"page":"110180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients"],"prefix":"10.1016","volume":"144","author":[{"given":"Bragi","family":"Lovetrue","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110180_b0005","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Jiang, M., Gao, L., & Huang, X., Single cell analysis of ACE2 expression reveals the potential targets for 2019-nCoV. (2020). doi:10.20944\/PREPRINTS202002.0221.V1.","DOI":"10.20944\/preprints202002.0221.v1"},{"key":"10.1016\/j.mehy.2020.110180_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/db12-0808","article-title":"Activation of the ACE2\/angiotensin-(1\u20137)\/mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors","volume":"62","author":"Jarajapu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2020.110180_b0015","first-page":"1","article-title":"The ACE2\/Ang-(1\u20137)\/Mas axis regulates the develop- ment of pancreatic endocrine cells in mouse embryos","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2020.110180_b0020","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3727\/096368914X685087","article-title":"Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury","volume":"24","author":"He","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.mehy.2020.110180_b0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bbagrm.2013.09.007","article-title":"The transcrip- tion factor HNF1\u03b1 induces expression of angiotensin-converting enzyme 2 (ACE2) in pancreatic islets from evolutionarily conserved promoter motifs","volume":"1829","author":"Pedersen","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2020.110180_b0030","doi-asserted-by":"crossref","article-title":"Tissue-specific expression of angiotensin-converting enzyme 2 (ACE2) from two promoter regions is unaffected by elevated levels of renin and angiotensinogen","author":"Nguyen","year":"2012","journal-title":"FASEB J","DOI":"10.1096\/fasebj.26.1_supplement.1134.9"},{"key":"10.1016\/j.mehy.2020.110180_b0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2020.110180_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","article-title":"Accessory proteins of SARS-CoV and other coronaviruses","volume":"109","author":"Liu","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.mehy.2020.110180_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2019.02.014","article-title":"Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway","volume":"42","author":"van Montfort","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2020.110180_b0055","unstructured":"Zhou, Y. et al. PERSPECTIVE Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients."},{"key":"10.1016\/j.mehy.2020.110180_b0060","first-page":"1","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study","volume":"6736","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110180_b0065","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"1\u201313","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2020.110180_b0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature24265","article-title":"Landscape of X chromosome inactivation across human tissues","volume":"550","author":"Tukiainen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2020.110180_b0075","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1161\/STROKEAHA.112.667063","article-title":"Impact of ACE2 deficiency and oxidative stress on cerebrovas-cular function with aging","volume":"43","author":"Pe\u00f1a-Silva","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2020.110180_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00012","article-title":"Source of chronic inflammation in aging","volume":"5","author":"Sanada","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.mehy.2020.110180_b0085","doi-asserted-by":"crossref","unstructured":"Mao, L. et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv 2020.02.22.20026500 (2020). doi:10.1101\/2020.02.22.20026500.","DOI":"10.1101\/2020.02.22.20026500"},{"key":"10.1016\/j.mehy.2020.110180_b0090","first-page":"1","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"2600","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.110180_b0095","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad7993","article-title":"Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation","volume":"352","author":"Rialdi","year":"2016","journal-title":"Science (80-)"},{"key":"10.1016\/j.mehy.2020.110180_b0100","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.mehy.2020.110180_b0105","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/bloodadvances.2017005561","article-title":"Proliferation through activation: Hemophagocytic lymphohistiocytosis in hematologic malignancy","volume":"1","author":"Vick","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.mehy.2020.110180_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock","year":"2015","journal-title":"Am J Hematol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720325408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T01:22:02Z","timestamp":1667784122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720325408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S0306987720325408"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2020.110180","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":["General Medicine"],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The AI-discovered aetiology of COVID-19 and rationale of the irinotecan+ etoposide combination therapy for critically ill COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Demiurge Technologies AG. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110180"}}
Abstract
We present the AI-discovered aetiology of COVID-19, based on a precise disease model of COVID-19 built under five weeks that best matches the epidemiological characteristics, transmission dynamics, clinical features, and biological properties of COVID-19 and consistently explains the rapidly expanding COVID-19 literature. We present that SARS-CoV-2 implements a unique unbiased survival strategy of balancing viral replication with viral spread by increasing its dependence on (i) ACE2-expressing cells for viral entry and spread, (ii) PI3K signaling in ACE2-expressing cells for viral replication and egress, and (iii) viral-non-structural-and-accessory-protein-dependent immunomodulation to balance viral spread and viral replication. We further propose the combination of irinotecan (an in-market topoisomerase I inhibitor) and etoposide (an in-market topoisomerase IIinhibitor) could potentially be an exceptionally effective treatment to protect critically ill patients from death causedby COVID-19-specific cytokine storms triggered by sepsis, ARDS, and other fatal comorbidities.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
